Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway

<div>KTZG-bioactive compounds and NAFLD-related target screening. (a) KTZG-bioactive compound network. (b) Screening of the protein-targeted KTZG for NAFLD treatment. KTZG: Kangtaizhi granule; NAFLD: nonalcoholic fatty liver disease.</div>

Journal of Immunology Research

fig1

Figure 1

Figure 1: Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway 